María José Safont

机构：Hospital General Universitario De Valencia · ORCID：0000-0003-4584-0452

发表论文 99 篇 · 总被引 3675 次 · h-index 22

代表论文

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial (2020 · The Lancet Oncology · 被引 1722)
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD) (2017 · European Journal of Cancer · 被引 89)
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study (2018 · European Journal of Cancer · 被引 84)
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial (2020 · ESMO Open · 被引 62)
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines (2021 · Clinical & Translational Oncology · 被引 51)
Gender and sex differences in colorectal cancer screening, diagnosis and treatment (2025 · Clinical & Translational Oncology · 被引 43)